ramelteon has been researched along with Diabetes Mellitus, Type 2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batyuk, A; Cherezov, V; Gati, C; Grandner, JM; Han, GW; Hao, S; Huang, XP; Johansson, LC; Katritch, V; Li, C; Liu, W; McCorvy, JD; Olsen, RHJ; Patel, N; Roth, BL; Slocum, ST; Stauch, B; Stevens, RC; Tribo, AR; Weierstall, U; Yous, S; Zaare, S; Zatsepin, NA; Zhu, L | 1 |
| Gilbert, M; Laustsen, G; Wimett, L | 1 |
2 other study(ies) available for ramelteon and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
XFEL structures of the human MT
Topics: Crystallization; Diabetes Mellitus, Type 2; Electrons; Humans; Indenes; Lasers; Ligands; Melatonin; Models, Molecular; Molecular Docking Simulation; Molecular Dynamics Simulation; Mutation; Receptor, Melatonin, MT1; Receptor, Melatonin, MT2; Structure-Activity Relationship; Substrate Specificity | 2019 |
A look back at the most influential drug approvals of 2005.
Topics: Amyloid; Analgesics; Anticonvulsants; Antiparkinson Agents; Diabetes Mellitus, Type 2; Diphtheria-Tetanus-Pertussis Vaccine; Drug Approval; Drug Combinations; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Exenatide; gamma-Aminobutyric Acid; Heart Failure; Humans; Hydralazine; Hypoglycemic Agents; Indenes; Indoles; Islet Amyloid Polypeptide; Isosorbide Dinitrate; Patient Education as Topic; Patient Selection; Peptides; Pregabalin; Sleep Wake Disorders; United States; United States Food and Drug Administration; Venoms | 2006 |